Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis

BACKGROUND: There is an unmet need for disease-modifying therapies to improve ambulatory function in disabled subjects with multiple sclerosis. OBJECTIVES: Assess the effects of natalizumab on ambulatory function in disabled subjects with relapsing-remitting multiple sclerosis (RRMS) or secondary pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cadavid, Diego, Jurgensen, Stephanie, Lee, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537666/
https://www.ncbi.nlm.nih.gov/pubmed/23308186
http://dx.doi.org/10.1371/journal.pone.0053297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537666/
https://www.ncbi.nlm.nih.gov/pubmed/23308186
http://dx.doi.org/10.1371/journal.pone.0053297

Ejemplares similares